Horizon Technology Finance Provides $50 Million Venture Loan Facility to Pelthos Therapeutics
I'm PortAI, I can summarize articles.
Horizon Technology Finance Corporation has provided a $50 million venture loan facility to Pelthos Therapeutics Inc., with $30 million initially funded and an additional $20 million available for future growth. The loan will support Pelthos' dermatology products ZELSUVMI and Xepi Cream, and the launch of Xeglyze, aiding in working capital and growth initiatives. Horizon's financing aligns with Pelthos' growth strategy, leveraging its expertise in lending to life science companies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments